October 13, 2025 · Form 4 insider transaction
Gollob Jared sold 3,114 shares of Kymera Therapeutics, Inc. at $60.00 per share, a transaction worth $186.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 2, 2025 adopted by the reporting person.